Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

ZURICH (Reuters) - Swiss drugmaker Roche (NYSE: ROG) said on Monday the U.S. Food and Drug Administration (FDA) had issued an Emergency Use Authorization (EUA) for its test for the Zika virus.

"The LightMix Zika test is an easy-to-use molecular diagnostic test that enables healthcare professionals to quickly detect the virus," said Uwe Oberlaender, the head of molecular diagnostics at Basel-based Roche.

The virus has been associated with microcephaly, a birth defect characterized by an unusually small head and potential developmental problems.